Dr. Lun Kelvin Tsou, associate Investigator of IBPR. Dr, Tsou with his team members had development a noval small molecule drug conjugate, DBPR115, that could target a biomarker phosphatidylserine and the deliver the anti-tumor agent to the tumor sites. By increasing the concentration of drug around the tumor, to decrease the side effects.

Dr. Tsou was awarded the 14th Tien Te Lee Biomedical Young Scientists Award, which was chosen by domestic/foreign scholars for his outstanding research achievement.
Reference Link： https://ibpr.nhri.org.tw/en/index.php/2018/08/16/a3/